Phase II study of 5-FU, doxorubicin, and mitomycin (FAM) and chlorozotocin in advanced measurable pancreatic cancer

F. P. Smith, V. K. Rustgi, G. Schertz, P. V. Woolley, P. S. Schein

Research output: Contribution to journalArticlepeer-review

7 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II study of 5-FU, doxorubicin, and mitomycin (FAM) and chlorozotocin in advanced measurable pancreatic cancer'. Together they form a unique fingerprint.